1. O-023FOLFOX/bevacizumab +/- irinotecan in advanced colorectal cancer (CHARTA): Long term outcome. (20th June 2018) Authors: Schmoll, H; Garlipp, B; Junghanß, C; Vogel, A; Kaiser, U; Florschütz, A; Kanzler, S; Hannig, C; Meinert, F; Cygon, F; Stein, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗